We thank Drs Yin, Lee, and Zhang for their comments on our article. Wong and colleagues[@bib1] reported that around 50% of pregnant women who developed severe acute respiratory syndrome (SARS) were admitted to the intensive care unit, and the mortality rate was as high as 25% for these women. In the current study, we recruited pregnant women with coronavirus disease 2019 (COVID-19) pneumonia from Jan. 20, 2020, to March 24, 2020. At the beginning of the pandemic, the information regarding COVID-19 in pregnancy was limited.[@bib2] Considering that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has up to 85% sequence similarity with SARS, we were afraid of the possibility that the disease course and prognosis of COVID-19 pneumonia could follow the same trend as SARS in pregnant women. Of note, 85 of 99 (85.9%) pregnant women in this study underwent a cesarean delivery. Some patients underwent cesarean delivery without obstetrical indications, because of uncertainty about the risk of SARS-CoV-2 infection in pregnancy.

SARS-CoV-2 infection itself is not an indication for delivery, unless there is a need to improve maternal and fetal outcomes. The timing and mode of delivery depended mainly on the clinical status of the patient, gestational age, and fetal condition. In the event that a pregnant woman with infection has spontaneous onset of labor with optimal progress, she could be allowed to deliver vaginally. However, the delivery should be accelerated when there is fetal distress, poor progress in labor, or deterioration in maternal condition. If a patient presented term and maternal condition deteriorates, then she would be delivered. The same logic applies for preterm COVID-19 cases after weighing the pros and cons.

Currently, there is still no evidence that pregnant women with COVID-19 are more prone to develop severe pneumonia compared with nonpregnant patients. The clinical characteristics of pregnant women with COVID-19 are similar to those of nonpregnant adults with COVID-19.[@bib3]
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